AbbVie Inc.
ABBVFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
56,334
Cost of Revenue
16,904
Gross Profit
39,430
Gross Margin
70.0%
Operating Income
9,137
Operating Margin
16.2%
Net Income
4,278
Net Margin
7.6%
EPS (Basic)
$2.40
EPS (Diluted)
$2.39
EBITDA
14,910
EBITDA Margin
26.5%
2023
12/31/2023
Revenue
54,318
Cost of Revenue
20,415
Gross Profit
33,903
Gross Margin
62.4%
Operating Income
12,757
Operating Margin
23.5%
Net Income
4,863
Net Margin
9.0%
EPS (Basic)
$2.73
EPS (Diluted)
$2.72
EBITDA
17,172
EBITDA Margin
31.6%
2022
12/31/2022
Revenue
58,054
Cost of Revenue
17,414
Gross Profit
40,640
Gross Margin
70.0%
Operating Income
18,117
Operating Margin
31.2%
Net Income
11,836
Net Margin
20.4%
EPS (Basic)
$6.65
EPS (Diluted)
$6.63
EBITDA
24,174
EBITDA Margin
41.6%
2021
12/31/2021
Revenue
56,197
Cost of Revenue
17,446
Gross Profit
38,751
Gross Margin
69.0%
Operating Income
17,924
Operating Margin
31.9%
Net Income
11,542
Net Margin
20.5%
EPS (Basic)
$6.48
EPS (Diluted)
$6.45
EBITDA
23,933
EBITDA Margin
42.6%
2020
12/31/2020
Revenue
45,804
Cost of Revenue
15,387
Gross Profit
30,417
Gross Margin
66.4%
Operating Income
11,363
Operating Margin
24.8%
Net Income
4,616
Net Margin
10.1%
EPS (Basic)
$2.73
EPS (Diluted)
$2.72
EBITDA
12,323
EBITDA Margin
26.9%